New advances in general biomedical applications of PAMAM dendrimers RV Araújo, SS Santos, E Igne Ferreira, J Giarolla Molecules 23 (11), 2849, 2018 | 263 | 2018 |
Dendrimers in the context of nanomedicine AP Dias, S da Silva Santos, JV da Silva, R Parise-Filho, EI Ferreira, ... International journal of pharmaceutics 573, 118814, 2020 | 227 | 2020 |
Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review SS Santos, RV de Araújo, J Giarolla, O El Seoud, EI Ferreira International journal of antimicrobial agents 55 (4), 105906, 2020 | 111 | 2020 |
Prodrugs for the treatment of neglected diseases MC Chung, EI Ferreira, JL Santos, J Giarolla, DG Rando, AE Almeida, ... Molecules 13 (3), 616-677, 2008 | 103 | 2008 |
Perspectives about self-immolative drug delivery systems RV Gonzaga, LA do Nascimento, SS Santos, BAM Sanches, J Giarolla, ... Journal of pharmaceutical sciences 109 (11), 3262-3281, 2020 | 57 | 2020 |
Dendrimer prodrugs S da Silva Santos, E Igne Ferreira, J Giarolla Molecules 21 (6), 686, 2016 | 53 | 2016 |
Peptide dendrimers: Drug/gene delivery and other approaches SS Santos, RV Gonzaga, JV Silva, DF Savino, D Prieto, JM Shikay, ... Canadian Journal of Chemistry 95 (9), 907-916, 2017 | 42 | 2017 |
Innovative approaches to an eco-friendly cosmetic industry: a review of sustainable ingredients R Sasounian, RM Martinez, AM Lopes, J Giarolla, C Rosado, ... Clean Technologies 6 (1), 176-198, 2024 | 25 | 2024 |
Molecular modeling as a promising tool to study dendrimer prodrugs delivery J Giarolla, DG Rando, KFM Pasqualoto, MH Zaim, EI Ferreira Journal of Molecular Structure: THEOCHEM 939 (1-3), 133-138, 2010 | 24 | 2010 |
Neglected tropical diseases and systemic racism especially in Brazil: from socio-economic aspects to the development of new drugs JR da Conceição, CPG Lopes, EI Ferreira, S Epiphanio, J Giarolla Acta Tropica 235, 106654, 2022 | 20 | 2022 |
Drug design for neglected disease in Brazil J Giarolla, E Igne Ferreira Mini Reviews in Medicinal Chemistry 15 (3), 220-242, 2015 | 20 | 2015 |
Molecular modeling study on the disassembly of dendrimers designed as potential antichagasic and antileishmanial prodrugs J Giarolla, KFM Pasqualoto, DG Rando, MH Zaim, EI Ferreira Journal of molecular modeling 18, 2257-2269, 2012 | 18 | 2012 |
PAMAM Dendrimers: A review of methodologies employed in biopharmaceutical classification F Guizze, CHR Serra, J Giarolla Journal of Pharmaceutical Sciences 111 (10), 2662-2673, 2022 | 16 | 2022 |
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies ES Vaz, SV Vassiliades, J Giarolla, MC Polli, R Parise-Filho European Journal of Clinical Pharmacology 79 (6), 723-751, 2023 | 15 | 2023 |
Targeting groups employed in selective dendrons and dendrimers R Vieira Gonzaga, S da Silva Santos, JV Da Silva, D Campos Prieto, ... Pharmaceutics 10 (4), 219, 2018 | 15 | 2018 |
Design and exploratory data analysis of a second generation of dendrimer prodrugs potentially antichagasic and leishmanicide J Giarolla, KFM Pasqualoto, EI Ferreira Molecular diversity 17, 711-720, 2013 | 15 | 2013 |
A review on carbon nanotubes family of nanomaterials and their health field CL Brito, JV Silva, RV Gonzaga, MA La-Scalea, J Giarolla, EI Ferreira ACS omega 9 (8), 8687-8708, 2024 | 14 | 2024 |
Malaria and tuberculosis as diseases of neglected populations: state of the art in chemotherapy and advances in the search for new drugs RV de Araújo, SS Santos, LM Sanches, J Giarolla, O El Seoud, EI Ferreira Memórias do Instituto Oswaldo Cruz 115, e200229, 2020 | 14 | 2020 |
Resveratrol and curcumin for Chagas disease treatment—a systematic review CHL Imperador, CB Scarim, PL Bosquesi, JR Lopes, A Cardinalli Neto, ... Pharmaceuticals 15 (5), 609, 2022 | 10 | 2022 |
Chalcones and N-acylhydrazones: direct analogues? Exploratory data analysis applied to potential novel antileishmanial agents DG Rando, J Giarolla, KFM Pasqualoto, EI Ferreira Brazilian Journal of Pharmaceutical Sciences 46, 311-321, 2010 | 9 | 2010 |